These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31245507)

  • 1. Recognition of, interest in, and understanding of induced pluripotent stem cells and regenerative medicine in Japanese students.
    Ishihara K; Ichinomiya A; Inami M; Hashimoto T; Yuzawa R; Ishizu M; Hirohara T; Yashiro Y; Takizawa T
    Regen Ther; 2016 Dec; 5():96-106. PubMed ID: 31245507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
    Nakamura M; Toyama Y; Okano H
    Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies.
    Azuma K; Yamanaka S
    Regen Ther; 2016 Jun; 4():36-47. PubMed ID: 31245486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells.
    Nakamura M; Okano H
    Cell Res; 2013 Jan; 23(1):70-80. PubMed ID: 23229514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in corneal regenerative medicine with iPS cells.
    Hatou S; Shimmura S
    Jpn J Ophthalmol; 2023 Sep; 67(5):541-545. PubMed ID: 37578549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells.
    Rami F; Beni SN; Kahnamooi MM; Rahimmanesh I; Salehi AR; Salehi R
    Cell Reprogram; 2017 Apr; 19(2):65-74. PubMed ID: 28266864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells.
    Hayakawa T; Aoi T; Umezawa A; Ozawa K; Sato Y; Sawa Y; Matsuyama A; Yamanaka S; Yamato M
    Regen Ther; 2015 Dec; 2():95-108. PubMed ID: 31245463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem (iPS) cells offer a powerful new tool for the life sciences.
    Nakamura Y
    J Stem Cells Regen Med; 2010; 6(1):2-9. PubMed ID: 24693054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of autologous human induced pluripotent stem(-like) cells.
    Hayakawa T; Aoi T; Umezawa A; Ozawa K; Sato Y; Sawa Y; Matsuyama A; Yamanaka S; Yamato M
    Regen Ther; 2015 Dec; 2():81-94. PubMed ID: 31245462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Analysis of Attitudes on Communication Toward Stem Cell Research and Regenerative Medicine Between the Public and the Scientific Community.
    Shineha R; Inoue Y; Ikka T; Kishimoto A; Yashiro Y
    Stem Cells Transl Med; 2018 Feb; 7(2):251-257. PubMed ID: 29372590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal Cell Therapy Using iPS Cells].
    Takahashi M
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):210-24; discussion 225. PubMed ID: 27164758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science communication in regenerative medicine: Implications for the role of academic society and science policy.
    Shineha R; Inoue Y; Ikka T; Kishimoto A; Yashiro Y
    Regen Ther; 2017 Dec; 7():89-97. PubMed ID: 30271857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current interest in careers in surgery and cardiothoracic surgery from the millennial generation.
    Ghannam M; Zhao L; Reddy RM
    J Surg Educ; 2014; 71(5):668-73. PubMed ID: 24831442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stem cell research and science and technology policy in Japan].
    Yashiro Y
    Nihon Rinsho; 2011 Dec; 69(12):2251-6. PubMed ID: 22242329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of the regulation and development of cell therapy products in Japan].
    Igarashi Y; Sato Y
    Nihon Yakurigaku Zasshi; 2018; 151(6):254-259. PubMed ID: 29887575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regenerative medicine for radiation emergencies.
    Higashi Y; Yusoff FM; Kishimoto S; Maruhashi T
    J Radiat Res; 2021 May; 62(Supplement_1):i21-i29. PubMed ID: 33978185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Social Framework Surrounding the Development of Regenerative Medicine in Japan.
    Nakazawa E; Takimoto Y; Akabayashi A
    Camb Q Healthc Ethics; 2016 Jul; 25(3):466-71. PubMed ID: 27348830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a student-driven undergraduate program in regenerative medicine.
    W Sandoval AG; Traktuev DO; March KL
    Regen Med; 2022 Oct; 17(10):755-765. PubMed ID: 35924471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.